BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25298080)

  • 1. Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.
    Grünblatt E; Riederer P
    J Neural Transm (Vienna); 2016 Feb; 123(2):83-90. PubMed ID: 25298080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde dehydrogenase 2 in sporadic Parkinson's disease.
    Michel TM; Käsbauer L; Gsell W; Jecel J; Sheldrick AJ; Cortese M; Nickl-Jockschat T; Grünblatt E; Riederer P
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S68-72. PubMed ID: 24262192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
    Wey MC; Fernandez E; Martinez PA; Sullivan P; Goldstein DS; Strong R
    PLoS One; 2012; 7(2):e31522. PubMed ID: 22384032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration.
    Chen CH; Joshi AU; Mochly-Rosen D
    Acta Neurol Taiwan; 2016 Dec; 25(4)(4):111-123. PubMed ID: 28382610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.
    Goldstein DS; Sullivan P; Holmes C; Miller GW; Alter S; Strong R; Mash DC; Kopin IJ; Sharabi Y
    J Neurochem; 2013 Sep; 126(5):591-603. PubMed ID: 23786406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration.
    Deza-Ponzio R; Herrera ML; Bellini MJ; Virgolini MB; Hereñú CB
    Neurotoxicology; 2018 Sep; 68():19-24. PubMed ID: 29936317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening.
    Kotraiah V; Pallares D; Toema D; Kong D; Beausoleil E
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):489-94. PubMed ID: 22380773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.
    Grünblatt E; Ruder J; Monoranu CM; Riederer P; Youdim MB; Mandel SA
    Neurotox Res; 2018 Apr; 33(3):560-568. PubMed ID: 29218503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.
    Fitzmaurice AG; Rhodes SL; Cockburn M; Ritz B; Bronstein JM
    Neurology; 2014 Feb; 82(5):419-26. PubMed ID: 24491970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.
    Michel TM; Gsell W; Käsbauer L; Tatschner T; Sheldrick AJ; Neuner I; Schneider F; Grünblatt E; Riederer P
    J Alzheimers Dis; 2010; 19(4):1295-301. PubMed ID: 20061610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism.
    Chiu CC; Yeh TH; Lai SC; Wu-Chou YH; Chen CH; Mochly-Rosen D; Huang YC; Chen YJ; Chen CL; Chang YM; Wang HL; Lu CS
    Exp Neurol; 2015 Jan; 263():244-53. PubMed ID: 25263579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification.
    Ohta S; Ohsawa I
    J Alzheimers Dis; 2006 Jul; 9(2):155-66. PubMed ID: 16873963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.
    Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H
    J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.
    Casida JE; Ford B; Jinsmaa Y; Sullivan P; Cooney A; Goldstein DS
    Chem Res Toxicol; 2014 Aug; 27(8):1359-61. PubMed ID: 25045800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases.
    Zhao Y; Wang C
    Biomed Res Int; 2015; 2015():174050. PubMed ID: 26491656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's disease.
    D'Souza Y; Elharram A; Soon-Shiong R; Andrew RD; Bennett BM
    Mol Brain; 2015 Apr; 8():27. PubMed ID: 25910195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.
    Makia NL; Bojang P; Falkner KC; Conklin DJ; Prough RA
    Chem Biol Interact; 2011 May; 191(1-3):278-87. PubMed ID: 21256123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High and complementary expression patterns of alcohol and aldehyde dehydrogenases in the gastrointestinal tract: implications for Parkinson's disease.
    Westerlund M; Belin AC; Felder MR; Olson L; Galter D
    FEBS J; 2007 Mar; 274(5):1212-23. PubMed ID: 17257171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.
    Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Kopin IJ; Sharabi Y
    J Neurochem; 2015 Apr; 133(1):14-25. PubMed ID: 25645689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.